Gerard Zalcman

Gerard Zalcman

UNVERIFIED PROFILE

Are you Gerard Zalcman?   Register this Author

Register author
Gerard Zalcman

Gerard Zalcman

Publications by authors named "Gerard Zalcman"

Are you Gerard Zalcman?   Register this Author

100Publications

4536Reads

17Profile Views

RASSF1A, puppeteer of cellular homeostasis, fights tumorigenesis, and metastasis-an updated review.

Cell Death Dis 2019 Dec 5;10(12):928. Epub 2019 Dec 5.

Normandie University, UNICAEN, CEA, CNRS, ISTCT/CERVOxy group, GIP CYCERON, Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41419-019-2169-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895193PMC
December 2019

RET-Rearranged Lung Adenocarcinoma with Paraneoplastic Meige Syndrome.

J Thorac Oncol 2019 Nov;14(11):e250-e251

Department of Thoracic Oncology, Hôpital Bichat, Assistance Publique des Hôpitaux de Paris, Paris, France; Paris Diderot University, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.06.008DOI Listing
November 2019

Health-Related Quality of Life Impact from Adding Bevacizumab to Cisplatin-Pemetrexed in Malignant Pleural Mesothelioma in the MAPS IFCT-GFPC-0701 Phase III Trial.

Clin Cancer Res 2019 Oct 7;25(19):5759-5765. Epub 2019 Jun 7.

Department of Thoracic Oncology, Centre d'investigation clinique Institut national de la santé et de la recherche médicale 1425, Hospital Bichat-Claude Bernard, Assistance Publique-Hôpitaux de Paris, Paris-Diderot University (Paris 7), Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-2860DOI Listing
October 2019

Trials of Prophylactic Irradiation of Tracts: What is the Appropriate End Point?

J Clin Oncol 2019 Oct 22;37(29):2693. Epub 2019 Aug 22.

Gérard Zalcman, MD, PhD, Hôpital Bichat, Université Paris-Diderot, Paris, France; and Solenn Brosseau, MD and Valérie Gounant, MD, CIC1425 INSERM, Hôpital Bichat-Claude Bernard, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.00927DOI Listing
October 2019

Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Members Reveals Specific Alteration Pattern in Diffuse Gliomas.

J Mol Diagn 2019 Jul 2;21(4):695-704. Epub 2019 May 2.

UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, Cyceron, a Public Interest Group, Normandy University, Caen, France; Department of Anatomy and Pathological Cytology, CHU de Caen, Caen, France; Department of Neuropathology, GHU Paris Psychiatry and Neuroscience, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2019.03.007DOI Listing
July 2019

Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer.

Lung Cancer 2019 06 8;132:65-71. Epub 2019 Apr 8.

Thoracic Oncology Department, University Hospital Bichat-Claude Bernard, Assistance Publique-Hôpitaux de Paris (AP-HP), 46 rue Henri Huchard, 75018, Paris, France; U830 INSERM "Genetics and biology of cancers", Research Centre, Institut Curie, 26 rue d'Ulm, 75005, Paris, France; Medicine Faculty, University Paris-Diderot, 46 rue Henri Huchard, 75018 Paris, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01695002193039
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2019.04.005DOI Listing
June 2019

Clinical Relevance of EGFR- or KRAS-mutated Subclones in Patients With Advanced Non-small-cell Lung Cancer Receiving Erlotinib in a French Prospective Cohort (IFCT ERMETIC2 Cohort - Part 2).

Clin Lung Cancer 2019 05 19;20(3):222-230. Epub 2018 Dec 19.

Intergroupe Francophone de Cancérologie Thoracique (IFCT), Paris, France; Service de Pneumologie, Assistance Publique Hôpitaux de Paris, Hôpital Tenon, GRC-04 Theranoscan, Université Paris VI, 75970 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.12.012DOI Listing
May 2019

Phase Ib/II study of the pan-cyclin-dependent kinase inhibitor roniciclib in combination with chemotherapy in patients with extensive-disease small-cell lung cancer.

Lung Cancer 2018 09 27;123:14-21. Epub 2018 Apr 27.

Aix Marseille University, Jardin du Pharo, 58, bd Charles Livon, 13284 Marseille, France; Assistance Publique Hôpitaux de Marseille, 80, rue Brochier, 13005 Marseille, France; Centre d'Essais Précoces en Cancérologie de Marseille (CLIP(2)), Hôpital La Timone - Basement F, 1st Floor, 264, rue St Pierre, 13885 Marseille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.04.022DOI Listing
September 2018

Minimal Change Disease Induced by Lorlatinib.

J Thorac Oncol 2018 08;13(8):e154-e156

Service de néphrologie, Hôpital Bichat-Claude Bernard, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.03.033DOI Listing
August 2018

(J)ALEX the great: a new era in the world of ALK inhibitors.

J Thorac Dis 2018 Jul;10(Suppl 18):S2138-S2143

Thoracic Oncology Department, University Hospital Bichat-Claude Bernard, University Paris-Diderot, Paris, France.

View Article

Download full-text PDF

Source
http://jtd.amegroups.com/article/view/22421/17258
Publisher Site
http://dx.doi.org/10.21037/jtd.2018.06.142DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072949PMC
July 2018

Immunotherapy in relapsed mesothelioma.

Immunotherapy 2018 02;10(2):77-80

Pulmonary & Thoracic Oncology, Univ Lille, CHU Lille, INSERM U1019, CIIL, Institut Pasteur de Lille, F59000 Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2017-0144DOI Listing
February 2018

Lazarus Syndrome With Crizotinib in a Non-Small Cell Lung Cancer Patient With ROS1 Rearrangement and Disseminated Intravascular Coagulation.

Clin Lung Cancer 2018 01 3;19(1):e57-e61. Epub 2017 Aug 3.

Service d'Oncologie Thoracique, CIC-1425/CLIP(2) Paris-Nord, Université Paris-Diderot, Hôpital Bichat-Claude Bernard, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.07.003DOI Listing
January 2018

Bevacizumab in advanced lung cancer: state of the art.

Future Oncol 2017 Dec 16;13(28):2515-2535. Epub 2017 Aug 16.

Department of Thoracic Oncology & CIC 1425/CLIP2 Paris-Nord, Bichat-Claude Bernard Hospital, APHP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0302DOI Listing
December 2017

A review of bevacizumab in the treatment of malignant pleural mesothelioma.

Future Oncol 2017 Dec 20;13(28):2537-2546. Epub 2017 Sep 20.

Department of Thoracic Oncology & CIC 1425/CLIP2 Paris-Nord, Bichat-Claude Bernard Hospital, APHP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0307DOI Listing
December 2017

Heart rate and risk of death among patients with Pulmonary Hypertension: A 12-lead ECG analysis.

Respir Med 2017 Nov 22;132:42-49. Epub 2017 Sep 22.

Department of Cardiology, CHU de Caen, Caen F-14000, France; Université de Caen Basse-Normandie, Medical School, Caen F-14000, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2017.09.008DOI Listing
November 2017

Morphologic and molecular study of lung cancers associated with idiopathic pulmonary fibrosis and other pulmonary fibroses.

Respir Res 2017 06 15;18(1):120. Epub 2017 Jun 15.

Département de Pathologie, Hôpital Bichat-Claude Bernard, Assistance Publique-Hôpitaux de Paris, 46 rue Henri Huchard, 75018, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12931-017-0605-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472872PMC
June 2017

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.

J Clin Oncol 2017 May 13;35(13):1403-1410. Epub 2017 Mar 13.

Oliver Gautschi, Kristin Zeidler, and Joachim Diebold, Lucerne Cantonal Hospital, Luzern; Patrizia Froesch, Ente Ospedaliero Cantonale, Bellinzona; Martin Früh, Kantonsspital St Gallen, St Gallen; Sacha I. Rothschild, University Hospital Basel, Basel, Switzerland; Julie Milia and Julien Mazières, Hôpital Larrey; Thomas Filleron, Institut Universitaire du Cancer, Claudius Regaud, Toulouse; Benjamin Besse and Jordi Remon-Masip, Institute Gustave Roussy, Villejuif; Gérard Zalcman, University Hospital Bichat, Paris; Isabelle Monnet, Centre Hospitalier Intercommunal de Creteil, Creteil; Florian Cabillic, Université de Rennes 1, Rennes, France; Juergen Wolf and Sebastian Michels, Center for Integrated Oncology, Cologne; Georg Pall, Fachkliniken Wangen, Wangen Im Allgäu; Arne Warth, Heidelberg University Hospital; Thomas Muley, Thoraxklinik at University of Heidelberg and Translational Lung Research Center, Heidelberg, Germany; David P. Carbone and Dwight Owen, Ohio State University Comprehensive Cancer Center, Columbus; Vamsidhar Velcheti, Cleveland Clinic, Pepper Pike, OH; Ross Camidge and Vignhesh Narayanan, University of Colorado, Denver; Robert C. Doebele, University of Colorado, Aurora, CO; Pasi A. Janne and Mark M. Awad, Dana-Farber Cancer Institute, Boston, MA; Daniel D. Karp, The University of Texas MD Anderson Cancer Center, Houston, TX; Heather A. Wakelee and Joel W. Neal, Stanford University, Stanford; Sai-Hong Ignatius Ou, University of California, Irvine, Orange; David R. Gandara and Jonathan W. Riess, University of California, Davis Cancer Center, Sacramento, CA; Alexander Drilon, Memorial Sloan Kettering Cancer Center, New York, NY; Nir Peled, Davidoff Cancer Center, Petach Tiqwa, Israël; Chul-Cho Byoung, Yonseï Cancer Center, Seoul, Republic of Korea; Michael Van Den Heuvel, Netherlands Cancer Institute, Amsterdam, the Netherlands; Tony S.K. Mok, The Chinese University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China; James C.H. Yang and Jin-Yuan Shih, National Taiwan University Hospital, Taipei, Republic of China; Sanjay Popat, Royal Marsden Hospital, London, United Kingdom; and Rafael Rosell and Niki Karachaliou, Catalan Institute of Oncology, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.9352DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559893PMC
May 2017

[Therapeutic advances in lung cancer].

Rev Prat 2017 01;67(1):47-50

Service d'oncologie thoracique, CIC1425/ CLIP2 Paris-Nord, université Paris- Diderot, hôpital Bichat-Claude-Bernard, AP-HP, Paris, France.

View Article

Download full-text PDF

Source
January 2017

Sensitivity to chemotherapy/tyrosine kinase inhibitors of mucinous lepidic adenocarcinoma should be tested in a phase III trial?

Eur Respir J 2016 06;47(6):1890-1

Intergroupe Francophone de Cancérologie Thoracique (IFCT), Paris, France Thoracic Oncology Dept, APHP Hôpital Bichat and Université Paris 7, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.01936-2015DOI Listing
June 2016

Pre-Emptive or Reactive Treatment of Cutaneous Rash Induced by Epidermal Growth Factor Receptor Inhibitors: Does It Matter?

J Clin Oncol 2016 Mar 28;34(8):774-6. Epub 2015 Dec 28.

Bichat-Claude Bernard University Hospital, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.7529DOI Listing
March 2016

[Malignant pleural mesothelioma: rare and aggressive but with new therapeutic perspectives].

Rev Prat 2016 Feb;66(2):191-197

Service d'oncologie thoracique, hôpital Bichat- Claude Bernard, université Paris-Diderot, Paris, France.

View Article

Download full-text PDF

Source
February 2016

Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort.

J Thorac Oncol 2015 Oct;10(10):1451-7

*Tumorzentrum, Luzerner Kantonsspital, Luzern, Switzerland; †Hôpital Larrey, Centre Hospital-Universitaire, Université Paul Sabatier, Toulouse, France; ‡Institut Claudius Regaud IUCT-O, Toulouse, France; §Institut Gustave Roussy, Villejuif, France; ¶VU University Medical Center, Amsterdam, The Netherlands; ‖Center of Integrated Oncology Cologne, University Hospital Cologne, Cologne, Germany; #Centre Pluridisciplinaire d'Oncologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; **Onkologie/Hämatologie, Kantonsspital St. Gallen, St. Gallen, Switzerland; ††Medizinische Klinik, St. Claraspital, Basel, Switzerland; ‡‡Service de pneumologie et oncologie thoracique, Hopital Universitaire, Caen, France; §§University Hospital Essen, Essen, Germany; ¶¶University Hospital Zurich, Zurich, Switzerland; ‖‖Clinique Teissier, Valenciennes, France; ##Centre Hospitalier Intercommunal de Creteil, Créteil, France; ***University Hospital Innsbruck, Innsbruck, Austria; †††University Hospital Basel, Basel, Switzerland; ‡‡‡Heidelberg University Medical Center, Mannheim, Germany; §§§Hopital du Haut Lévèque, Pessac, France; ¶¶¶Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; and ‖‖‖Centre Hospitalier Universitaire, Université de Caen-Basse Normandie, Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000625DOI Listing
October 2015

Do atmospheric conditions influence the first episode of primary spontaneous pneumothorax?

Interact Cardiovasc Thorac Surg 2015 Sep 1;21(3):296-300. Epub 2015 Jun 1.

Department of Pulmonary Medicine, University Hospital of Caen, Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/icvts/ivv145DOI Listing
September 2015

[Resistances to targeted therapies and strategy for following therapeutic lines in metastatic NSCLC].

Bull Cancer 2015 Jun;102(6 Suppl 1):S27-33

Service de pneumologie et oncologie thoracique, Université de Caen-Basse Normandie, Hôpital de la Côte-de-Nacre, 14033 Caen CS 3001, France; UMR Inserm 1086 Cancers et préventions, Université de Caen-Basse Normandie, Hôpital de la Côte-de-Nacre, 14033 Caen CS 3001, France; Centre de recherche clinique/Essais de phases précoces, Université de Caen-Basse Normandie, Hôpital de la Côte-de-Nacre, 14033 Caen CS 3001, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0007-4551(15)31215-7DOI Listing
June 2015

[Molecular targeted therapies and cytotoxics: Friends or foes?].

Bull Cancer 2015 Jun;102(6 Suppl 1):S91-2

Service de pneumologie et oncologie thoracique, Université de Caen-Basse Normandie, Hôpital de la Côte-de-Nacre, 14033 Caen CS 3001, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0007-4551(15)31223-6DOI Listing
June 2015

Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort.

J Clin Oncol 2015 Mar 9;33(9):992-9. Epub 2015 Feb 9.

Julien Mazières, Damien Rouvière, and Julie D. Milia, Hôpital Larrey, Centre Hospitalier Universitaire, Université Paul Sabatier; Thomas Filleron, Institut Universitaire du Cancer, Toulouse; Gérard Zalcman, Centre Hospitalier Universitaire, Université de Caen-Basse Normandie, Caen; Pamela Biondani and Benjamin Besse, Gustave Roussy, Villejuif; Fabrice Barlesi, Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, Marseille; Hervé Léna, Centre Hospitalier Universitaire, Rennes; Isabelle Monnet, Centre Hospitalier Intercommunal de Créteil, Créteil; Luc Thiberville, Centre Hospitalier Universitaire, Rouen; Nicolas Pecuchet, Institut Curie, Paris, France; Lucio Crinò, Medica-Azienda Ospedaliera, Perugia; Federico Cappuzzo, Istituto Toscano Tumori, Ospedale Civile, Livorno, Italy; Anne-Marie C. Dingemans, Maastricht University Medical Center, Maastricht; Egbert F. Smit, VU University Medical Center, Amsterdam, the Netherlands; Sacha I. Rothschild, University Hospital Basel, Medical Oncology, Basel; Christian Spirig, Klinik St Anna; Joachim Diebold and Oliver Gautschi, Cantonal Hospital Luzern, Lucerne, Switzerland; Rafal Dziadziuszko, Gdansk Medical University, Gdansk, Poland; Jurgen Wolf and Roman K. Thomas, Center of Integrated Oncology Köln-Bonn, University Hospital Cologne, University of Cologne; Frauke Leenders and Roman K. Thomas, University of Cologne; Johannes M. Heuckmann, Blackfield AG, Cologne, Germany.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/02/03/JCO.2014.58
Web Search
http://jco.ascopubs.org/content/early/2015/02/03/JCO.2014.58
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.58.3302
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.58.3302DOI Listing
March 2015

ALK-rearranged non-small cell lung cancers: how best to optimize the safety of crizotinib in clinical practice?

Expert Rev Anticancer Ther 2015 Feb 21;15(2):225-33. Epub 2014 Nov 21.

Department of Respiratory Medicine and Thoracic Oncology, Hôpital Louis Pradel, Hospices Civils de Lyon, Claude Bernard University Lyon 1, Lyon, France.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/14737140.2014.98
Publisher Site
http://dx.doi.org/10.1586/14737140.2014.986103DOI Listing
February 2015

[ALK-rearranged non-small cell lung cancer: how to optimize treatment with crizotinib in routine practice?].

Bull Cancer 2014 Sep;101(9):823-31

AP-HP Marseille, Université Aix-Marseille, Service d'oncologie multidisciplinaire & innovations thérapeutiques, 13015 Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2014.1976DOI Listing
September 2014

Customized adjuvant phase II trial in patients with non-small-cell lung cancer: IFCT-0801 TASTE.

J Clin Oncol 2014 Apr 17;32(12):1256-61. Epub 2014 Mar 17.

Marie Wislez and Jacques Cadranel, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris; Franck Morin, Intergroupe Francophone de Cancérologie Thoracique, Paris; Fabrice Barlesi, Aix Marseille University, Assistance Publique des Hôpitaux de Marseille; Anne Madroszyck, Institut Paoli Calmettes, Marseille; Benjamin Besse and Jean-Charles Soria, Institut Gustave Roussy, Villejuif; Julien Mazières, Hôpital Larrey, Toulouse; Patrick Merle, Centre Hospitalier Universitaire (CHU) de Clermont-Ferrand, Clermont-Ferrand; Clarisse Audigier-Valette, Hôpital Sainte Musse, Toulon; Denis Moro-Sibilot, CHU de Grenoble, Grenoble; Laure Gautier-Felizot, Centre Hospitalier de Dax, Dax; François Goupil, Centre Hospitalier du Mans, Le Mans; Aldo Renault, Centre Hospitalier de Pau, Pau; Elisabeth Quoix, Nouvel Hôpital Strasbourg, Strasbourg; Pierre-Jean Souquet, Centre Hospitalier Lyon-Sud; David Pérol, Centre Léon Bérard, Lyon; Romain Corre, Hôpital Pontchaillou, Rennes; and Gérard Zalcman, CHU Caen, Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.1525DOI Listing
April 2014

Reply to letter.

Eur J Cancer 2014 Feb 10;50(3):678. Epub 2013 Dec 10.

Centre Hospitalier Tenon, Hôpitaux de Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2013.11.019DOI Listing
February 2014

[Malignant pleural mesothelioma: 2013 state of the art].

Bull Cancer 2013 Dec;100(12):1283-93

Université de Caen-Basse Normandie, CHU de Caen, service de pneumologie et oncologie thoracique, avenue de la Côte-de-Nacre, 14033 Caen cedex 05, France, CHU de Caen, UMR Inserm 1086 « Cancers et Préventions », avenue Côte-de-Nacre, 14033 Caen Cedex 05 France, Intergroupe francophone de cancérologie thoracique (IFCT), 10, rue de la Grange-Batelière, 75009 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2013.1857DOI Listing
December 2013

Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy.

Eur Respir Rev 2013 Dec;22(130):565-76

Service de Pneumologie et Oncologie Thoracique, CHU Côte de Nacre, Caen, 2 U1086 INSERM Cancers et Préventions, Faculty of Medicine de Caen, Caen, 3 Intergroupe Francophone de Cancérologie Thoracique (IFCT), Paris, and 4 Département d'Anatomie Pathologique et Laboratoire d'Histologie, CHU Côte de Nacre, Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/09059180.00007113DOI Listing
December 2013

Does bilobectomy offer satisfactory long-term survival outcome for non-small cell lung cancer?

Ann Thorac Surg 2013 May 2;95(5):1726-33. Epub 2013 Apr 2.

Department of Thoracic Surgery, University Hospital of Caen, Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2013.01.071DOI Listing
May 2013

Lung cancer in never smokers--a review.

Eur J Cancer 2012 Jun 28;48(9):1299-311. Epub 2012 Mar 28.

Service de Pneumologie et Oncologie Thoracique, Hospices Civils de Lyon, CH Lyon Sud, et Université Lyon 1, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2012.03.007DOI Listing
June 2012

A STEPP too far for FLEX?

Lancet Oncol 2012 Feb;13(2):e51; author reply e51

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(12)70056-6DOI Listing
February 2012

Chemotherapy in elderly patients with advanced non-small cell lung cancer.

Lung Cancer 2011 Dec 3;74(3):364-8. Epub 2011 Sep 3.

University Hospital, Strasbourg cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2011.06.006DOI Listing
December 2011

Myocardial strain assessment in cystic fibrosis.

J Am Soc Echocardiogr 2011 Sep 18;24(9):1037-45. Epub 2011 Jul 18.

Department of Cardiology, CHU de Caen, Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.echo.2011.06.004DOI Listing
September 2011

[Prognostic and predictive biomarkers in non-small cell lung cancers. From conditioned registrations to routine molecular mapping of lung cancers: Methodological issues].

Presse Med 2011 Apr 3;40(4 Pt 1):379-88. Epub 2011 Mar 3.

CHU Côte de Nacre, université de Caen-Basse Normandie, service de pneumologie et oncologie thoracique, 14033 Caen cedex 05, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lpm.2011.01.016DOI Listing
April 2011